-
Something wrong with this record ?
High-risk neuroblastoma survivors show signs of immunosenescence early after therapy and retain increased myeloid cell activation status
P. Lázničková, M. H. Kohoutková, T. Kepák, Z. Křenová, T. Feglarová, A. Koladiya, J. Musil, K. Bendičková, J. Frič
Status not-indexed Language English Country Czech Republic
Document type Meeting Abstract
- Publication type
- Meeting Abstract MeSH
Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Hematology and Blood Transfusion Prague Czech Republic
Pediatric Hematology and Oncology University Hospital Brno Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22027146
- 003
- CZ-PrNML
- 005
- 20221116103758.0
- 007
- ta
- 008
- 221115s2022 xr f 00 0|eng||
- 009
- PC
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Lázničková, P. $u Cellular and Molecular Immunoregulation Group, Center for Translational Medicine, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 10
- $a High-risk neuroblastoma survivors show signs of immunosenescence early after therapy and retain increased myeloid cell activation status / $c P. Lázničková, M. H. Kohoutková, T. Kepák, Z. Křenová, T. Feglarová, A. Koladiya, J. Musil, K. Bendičková, J. Frič
- 590 __
- $a NEINDEXOVÁNO
- 655 _7
- $a abstrakt z konference $7 D016416 $2 czmesh
- 700 1_
- $a Kohoutková, M. H. $u Cellular and Molecular Immunoregulation Group, Center for Translational Medicine, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Kepák, Tomáš $7 xx0081397 $u Pediatric Oncology Translational Research, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $u Pediatric Hematology and Oncology, University Hospital, Brno, Czech Republic
- 700 1_
- $a Křenová, Zdenka $7 xx0118803 $u Pediatric Oncology Translational Research, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $u Pediatric Hematology and Oncology, University Hospital, Brno, Czech Republic
- 700 1_
- $a Feglarová, T. $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Koladiya, A. $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Musil, Jan $7 xx0210384 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Bendičková, K. $u Cellular and Molecular Immunoregulation Group, Center for Translational Medicine, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
- 700 1_
- $a Frič, J. $u Cellular and Molecular Immunoregulation Group, Center for Translational Medicine, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 773 0_
- $t Prague Onco Journal. 13. pražské mezioborové onkologické kolokvium Prague ONCO, 26.-28. ledna 2022 $x 1804-2252 $z 978-80-87339-26-8 $g Roč. 2022, č. 1 (2022), s. 39 $w MED00177652
- 773 0_
- $t Prague Onco Journal $x 1804-2252 $g (2022), s. 39 $w MED00177652
- 910 __
- $a ABA008 $b B 2634 $c 664 $y p $z 0
- 990 __
- $a 20221109140606 $b ABA008
- 991 __
- $a 20221116105002 $b ABA008
- 999 __
- $a ok $b bmc $g 1860119 $s 1178456
- BAS __
- $a 6
- BMC __
- $a 2022 $b 2022 $c 1 $d 39 $z 978-80-87339-26-8 $i 1804-2252 $m Prague Onco Journal $n Prague Onco J. $o 13. pražské mezioborové onkologické kolokvium Prague ONCO, 26.-28. ledna 2022 $x MED00177652
- BMC __
- $a 2022 $d 39 $i 1804-2252 $m Prague Onco Journal $x MED00177652
- LZP __
- $a NLK 2022-40/dkbi